Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Rupatadine

A second-generation, non-sedating, long-acting antihistamine developed in Spain and on the market since 2003: it is approved for allergic rhinitis and chronic urticaria. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Besides histamine it also blocks PAF, platelet-activating factor, another mediator of allergy. In the body it is partly converted into desloratadine, itself an antihistamine.

RupatadineGo to the active ingredient →
RupatadineActive ingredientRupatadineCat. No. P-R098-001CAS 158876-82-5

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.